Bifidobacterium infantis 35624
A highly specific strain with robust clinical data supporting its use in managing Irritable Bowel Syndrome (IBS).
Clinical Trial Data
| Study Focus | Result | Dose |
|---|---|---|
| IBS Global Symptoms | Significant reduction vs placebo | 1 x 10^8 CFU |
| Bloating / Distension | Significant reduction | 1 x 10^8 CFU |